XML 45 R32.htm IDEA: XBRL DOCUMENT v3.26.1
Significant Accounting Policies (Details) - USD ($)
1 Months Ended 3 Months Ended
Mar. 31, 2026
Mar. 31, 2026
Mar. 31, 2025
Dec. 31, 2025
Franchisor Disclosure [Line Items]        
Off-balance sheet concentrations of credit risk $ 0 $ 0   $ 0
Equity securities without readily determinable fair value, impairment loss   0 $ 0  
Restricted cash 3,100,000 $ 3,100,000   3,100,000
Royalty Pharma | Royalty Agreement        
Franchisor Disclosure [Line Items]        
Authorized funding       $ 275,000,000.0
Royalty rate       9.25%
Proceeds recieved $ 200,000,000.0